Litcius/Paper detail

Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled Trial

Ting Bao, Wanqing Iris Zhi, Raymond E. Baser, Madeline J. Hooper, Connie Chen, Lauren Piulson, Qing S. Li, Mary Lou Galantino, Victoria Blinder, Mark E. Robson, Andrew D. Seidman, Katherine S. Panageas, Jun J. Mao

2020JNCI Cancer Spectrum64 citationsDOIOpen Access PDF

Abstract

Abstract Background Chemotherapy-induced peripheral neuropathy (CIPN) is a common, debilitating side effect that worsens quality of life and increases the risk of falls in cancer survivors. Evidence of yoga’s safety and efficacy in treating CIPN is lacking. Methods In a randomized controlled study, we assigned breast and gynecological cancer survivors with persistent moderate-to-severe CIPN pain, numbness, or tingling with a score of 4 or greater (0-10 numeric rating scale [NRS]) for at least 3 months after chemotherapy to 8 weeks of usual care or yoga focused on breathwork and musculoskeletal conditioning. Primary endpoint was treatment arm differences for NRS, and secondary endpoints were Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx), and Functional Reach Test after week 8. We tested treatment arm differences for each outcome measure using linear mixed models with treatment-by-time interactions. All statistical tests were two-sided. Results We randomly assigned 41 participants into yoga (n = 21) or usual care (n = 20). At week 8, mean NRS pain decreased by 1.95 points (95% confidence interval [CI] = -3.20 to -0.70) in yoga vs 0.65 (95% CI = -1.81 to 0.51) in usual care (P = .14). FACT/GOG-Ntx improved by 4.25 (95% CI = 2.29 to 6.20) in yoga vs 1.36 (95% CI = -0.47 to 3.19) in usual care (P = .035). Functional reach, an objective functional measure predicting the risk of falls, improved by 7.14 cm (95% CI = 3.68 to 10.59) in yoga and decreased by 1.65 cm (95% CI = -5.00 to 1.72) in usual care (P = .001). Four grade 1 adverse events were observed in the yoga arm. Conclusion Among breast and gynecological cancer survivors with moderate-to-severe CIPN, yoga was safe and showed promising efficacy in improving CIPN symptoms.

Topics & Concepts

MedicineChemotherapy-induced peripheral neuropathyRandomized controlled trialPeripheral neuropathyQuality of life (healthcare)Gynecologic oncologyConfidence intervalPhysical therapyBreast cancerInternal medicineClinical endpointAdverse effectCancerNursingEndocrinologyDiabetes mellitusCancer Treatment and PharmacologyChemotherapy-related skin toxicityCancer-related cognitive impairment studies